L. Canullo

Available oral lipid-lowering agents could bring most high-risk patients to target: an estimate based on the Dyslipidemia International Study II-Italy

C. Cuccia, A. Gitt, G. Perna, 2018, Journal of cardiovascular medicine.

37th International Symposium on Intensive Care and Emergency Medicine (part 2 of 3)

G. Auzinger, D. Pavelescu, M. Dickinson, 2017, Critical Care.

Lipid Lowering Treatment and Follow Up in Recent Post Acute Coronary Syndrome Patients: Real-World Evidence from the Multicenter Observational Prospective - Post Acute Coronary Syndrome Italian Study (PACSI)

F. Fattirolli, R. Rossini, G. Patti, 2020 .

Novel potent and selective central 5-HT3 receptor ligands provided with different intrinsic efficacy. 2. Molecular basis of the intrinsic efficacy of arylpiperazine derivatives at the central 5-HT3 receptors.

M. Hamon, M. Menziani, É. Doucet, 1999, Journal of medicinal chemistry.

Synthesis, biological evaluation, and receptor docking simulations of 2-[(acylamino)ethyl]-1,4-benzodiazepines as kappa-opioid receptor agonists endowed with antinociceptive and antiamnesic activity.

Simona Collina, Andrea Gallelli, S. Collina, 2003, Journal of medicinal chemistry.

37th International Symposium on Intensive Care and Emergency Medicine (part 3 of 3)

Hester F. Lingsma, J. M. Vieira, M. Majdan, 2017, Critical Care.

37th International Symposium on Intensive Care and Emergency Medicine (part 3 of 3)

Hester F. Lingsma, J. M. Vieira, M. Majdan, 2017, Critical Care.